Measured Wealth Private Client Group’s Exelixis EXEL Stock Holding History

Measured Wealth Private Client Group’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.3K	Sell	373 -411	-52%	-$20K	﹤0.01%	485
2026 Q1	$33.6K	Sell	784 -4,690	-86%	-$202K	0.01%	357
2025 Q4	$240K	Sell	5,474 -8,719	-61%	-$361K	0.06%	165
2025 Q3	$586K	Buy	14,193 +635	+5%	+$25.5K	0.16%	89
2025 Q2	$598K	Buy	13,558 +2,112	+18%	+$84.4K	0.18%	84
2025 Q1	$423K	Buy	+11,446	New	+$408K	0.14%	107

Other funds holding EXEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Measured Wealth Private Client Group's EXEL Position: Q2 2026 in Review

Measured Wealth Private Client Group reduced its Exelixis (EXEL) stake by 52% in Q2 2026, selling an estimated $20K and leaving 373 shares worth $20.3K. The position accounts for ﹤0.01% of the portfolio, ranked #485.

Measured Wealth Private Client Group first reported a position in EXEL in Q1 2025 and has held it in 6 quarters since. The position peaked at $598K in Q2 2025. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

Measured Wealth Private Client Group held 373 shares of Exelixis worth $20.3K as of Q2 2026.
Measured Wealth Private Client Group sold 411 Exelixis shares in Q2 2026, an estimated $20K.
Exelixis made up ﹤0.01% of Measured Wealth Private Client Group's portfolio in Q2 2026, its #485 holding.
Measured Wealth Private Client Group first reported a position in Exelixis in Q1 2025 and has held it in 6 quarters since.
Measured Wealth Private Client Group's Exelixis position peaked at $598K in Q2 2025.
758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Measured Wealth Private Client Group's 13F filing for Q2 2026, filed 10 Aug 2026.